IN2013MU03544A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03544A
IN2013MU03544A IN3544MU2013A IN2013MU03544A IN 2013MU03544 A IN2013MU03544 A IN 2013MU03544A IN 3544MU2013 A IN3544MU2013 A IN 3544MU2013A IN 2013MU03544 A IN2013MU03544 A IN 2013MU03544A
Authority
IN
India
Prior art keywords
present
stable pharmaceutical
zwitterionic
drug
relates
Prior art date
Application number
Other languages
English (en)
Inventor
Vandana Bharat Patravale;
Clara Bernard Fernandes;
Ankit Ashokbhai Agarwal;
Original Assignee
Vandana Bharat Patravale;
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vandana Bharat Patravale; filed Critical Vandana Bharat Patravale;
Priority to IN3544MU2013 priority Critical patent/IN2013MU03544A/en
Publication of IN2013MU03544A publication Critical patent/IN2013MU03544A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
IN3544MU2013 2013-11-11 2013-11-11 IN2013MU03544A (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3544MU2013 IN2013MU03544A (da) 2013-11-11 2013-11-11

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3544MU2013 IN2013MU03544A (da) 2013-11-11 2013-11-11

Publications (1)

Publication Number Publication Date
IN2013MU03544A true IN2013MU03544A (da) 2015-07-24

Family

ID=54397557

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3544MU2013 IN2013MU03544A (da) 2013-11-11 2013-11-11

Country Status (1)

Country Link
IN (1) IN2013MU03544A (da)

Similar Documents

Publication Publication Date Title
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
PE20160541A1 (es) Formulaciones de anticuerpos anti-pdl1
EA201591003A1 (ru) Производные бороновой кислоты и их терапевтическое применение
PH12015502013A1 (en) Pharmaceutical composition of s-ketamine hydrochloride
PH12015501957A1 (en) Pharmaceutical composition of s-ketamine hydrochloride
MX2016005395A (es) Formulacion estable de insulina glulisina.
PH12016501122A1 (en) Delayed release compositions of linaclotide
IN2014MN02213A (da)
EP3034082A4 (en) Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients
MX2016001422A (es) Composicion farmaceutica de fingolimod.
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
MX2017009289A (es) Formulaciones farmaceuticas que comprenden cangrelor de alta pureza y metodos para preparar y utilizar las mismas.
PH12016502544B1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
PH12016501117A1 (en) Pharmaceutical compositions of carotenoid
MX2018002859A (es) Extracto de gardenia para colorear la piel.
EA201691741A1 (ru) Фармацевтическая композиция
MX2015015537A (es) Formulacion de pastillas de nicotina.
WO2012104874A3 (en) Aqueous concentrated formulation of linezolid
IN2013MU03544A (da)
EA201891848A1 (ru) Фармацевтическая композиция для применения в лечении фиброза
EA201491477A1 (ru) Фармацевтические составы, содержащие флупиртин
GT201500116A (es) Mètodo para preparar derivados de feniloximetil-nitro-imidazol y su uso del mismo